Glaucoma
Cannabis has been explored as a potential treatment for glaucoma, a condition characterized by increased intraocular pressure (IOP) that can lead to optic nerve damage and vision loss. Cannabinoids such as tetrahydrocannabinol (THC) have been shown to lower IOP by relaxing the trabecular meshwork, improving aqueous humor outflow, and reducing production of intraocular fluid (Hepler & Frank, 1971). This effect can provide temporary relief, which may benefit patients resistant to traditional medications.
Research indicates that THC not only reduces IOP but may also possess neuroprotective properties, potentially safeguarding retinal cells from degeneration (Chen et al., 2005).
Additionally, cannabis can alleviate symptoms associated with glaucoma, such as eye pain and headaches, improving patients’ overall quality of life (Tomida et al., 2006).
However, the therapeutic use of cannabis for glaucoma is limited by its short duration of action, typically lasting only 3–4 hours, requiring frequent dosing that can lead to systemic side effects like dizziness or cognitive impairment. While promising, cannabis is not yet a first-line treatment for glaucoma, and ongoing studies are needed to explore long-term safety and efficacy.
References
- 1. Chen, J., Matias, I., Dinh, T., et al. (2005). Neuroprotection by cannabinoids against retinal neurodegeneration. The Journal of Neuroscience, 25(5), 1166-1172.
- 2. Hepler, R. S., & Frank, I. M. (1971). Marijuana smoking and intraocular pressure. JAMA, 217(10), 1392.
- 3. Novack, G. D. (2016). Cannabinoids for treatment of glaucoma. Current Opinion in Ophthalmology, 27(2), 146-150.
- 4. Tomida, I., Pertwee, R. G., & Azuara-Blanco, A. (2006). Cannabinoids and glaucoma. British Journal of Ophthalmology, 90(7), 839-843.
- 5. Wang, J., Lu, Y., & Feng, Y. (2020). Cannabinoid therapy in glaucoma management: an update. Neuropharmacology, 175, 108174.
Servicios relacionados
Cannabis has garnered attention as a potential adjunct therapy for bipolar disorder, offering therapeutic benefits when used…
Cannabis has emerged as a complementary option in managing cancer-related symptoms, providing…
Cannabis has shown promise as a therapeutic option for managing Crohn’s disease, a chronic…
Cannabis has gained recognition as a potential therapy for managing chronic pain, offering relief…
Cannabis is being explored as a potential adjunct therapy for managing depression, offering…
Cannabis, particularly cannabidiol (CBD) has shown significant promise in managing epilepsy,…
Cannabis is being studied as a potential therapy for managing pain associated with gout, a form of…
Cannabis is being explored as a complementary therapy for managing symptoms associated with….
Cannabis has demonstrated potential in improving the quality of life for individuals living with..
Cannabis has been studied for its potential to help manage hypertension (high blood pressure), a…
Cannabis has gained as a potential treatment for Irritable Bowel Syndrome (IBS), a gastrointestinal disorder…
Cannabis has gained attention as a potential treatment for insomnia, a common sleep disorder..
Cannabis has shown potential in the treatment of migraines, a neurological condition characterized…
Cannabis has shown potential as a therapeutic option for managing symptons of multiple sclerosis (MS), a chronic…